Long-term efficacy and safety of Canakinumab in active Hyper-IgD syndrome (HIDS): results from an open-label study

被引:0
|
作者
JI Aróstegui
J Anton
I Calvo
A Robles
A Speziale
Y Joubert
G Junge
J Yagüe
机构
[1] Hospital Clinic,
[2] Hospital Sant Joan de Déu,undefined
[3] Hospital La Fe,undefined
[4] Hospital La Paz,undefined
[5] Novartis Pharma AG,undefined
[6] Hospital Clinic,undefined
关键词
Withdrawal Period; Canakinumab; Periodic Fever Syndrome; Global Assessment Score; HIDS Patient;
D O I
10.1186/1546-0096-13-S1-O58
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [21] Long-Term Efficacy, Safety, and Pharmacokinetics of Drisapersen in Duchenne Muscular Dystrophy: Results from an Open-Label Extension Study
    Goemans, Nathalie M.
    Tulinius, Mar
    van den Hauwe, Marleen
    Kroksmark, Anna-Karin
    Buyse, Gunnar
    Wilson, Rosamund J.
    van Deutekom, Judith C.
    de Kimpe, Sjef J.
    Lourbakos, Afrodite
    Campion, Giles
    PLOS ONE, 2016, 11 (09):
  • [22] Long-term safety and efficacy of ozanimod in relapsing multiple sclerosis: results from the DAYBREAK open-label extension study
    Steinman, L.
    Comi, G.
    Bar-Or, A.
    Selmaj, K. W.
    Arnold, D. L.
    Hartung, H. -P.
    Montalban, X.
    Havrdova, E. K.
    Sheffield, J. K.
    Minton, N.
    Janjua, A.
    Huang, V.
    Silva, D.
    Kappos, L.
    Cohen, J. A.
    Cree, B. A. C.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 548 - 549
  • [23] LONG-TERM EFFICACY OF LANADELUMAB: INTERIM RESULTS FROM THE HELP OPEN-LABEL EXTENSION STUDY
    Riedl, M.
    Cicardi, M.
    Hao, J.
    Lu, P.
    Li, H.
    Manning, M.
    Bernstein, J.
    Busse, P.
    Tachdjian, R.
    Gower, R.
    Wedner, H.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2019, 123 (05) : S30 - S31
  • [24] Long-term efficacy and safety of omalizumab for nasal polyposis in an open-label extension study
    Gevaert, Philippe
    Saenz, Rebecca
    Corren, Jonathan
    Han, Joseph K.
    Mullol, Joaquim
    Lee, Stella E.
    Ow, Randall A.
    Zhao, Rui
    Howard, Monet
    Wong, Kit
    Islam, Lutaf
    Ligueros-Saylan, Monica
    Omachi, Theodore A.
    Bachert, Claus
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2022, 149 (03) : 957 - +
  • [25] Long-term safety and antihypertensive efficacy of irbesartan: Pooled results of five open-label studies
    Littlejohn, T
    Saini, R
    Kassler-Taub, K
    Crysant, SG
    Marbury, T
    CLINICAL AND EXPERIMENTAL HYPERTENSION, 1999, 21 (08) : 1273 - 1295
  • [26] Safety and efficacy of eltrombopag for treatment of chronic immune thrombocytopenia: results of the long-term, open-label EXTEND study
    Saleh, Mansoor N.
    Bussel, James B.
    Cheng, Gregory
    Meyer, Oliver
    Bailey, Christine K.
    Arning, Michael
    Brainsky, Andres
    BLOOD, 2013, 121 (03) : 537 - 545
  • [27] Open-label study of the long-term efficacy and safety of pramipexole in patients with Restless Legs Syndrome (extension of the PRELUDE study)
    Partinen, Markku
    Hirvonen, Kari
    Jama, Leni
    Alakuijala, Anniina
    Hublin, Christer
    Tamminen, Ilkka
    Koester, Juergen
    Reess, Juergen
    SLEEP MEDICINE, 2008, 9 (05) : 537 - 541
  • [28] Long-Term Efficacy of Adjunctive Cariprazine in Patients With MDD: Results From an Open-Label 26-Week Safety Study
    Masand, Prakash
    Vieta, Eduard
    Waraich, Simranpreet
    Kramer, Ken
    Kerolous, Majid
    NEUROPSYCHOPHARMACOLOGY, 2023, 48 : 263 - 264
  • [29] Long-term safety and efficacy of add-on cannabidiol in patients with Lennox-Gastaut syndrome: Results of a long-term open-label extension trial
    Patel, Anup D.
    Mazurkiewicz-Beldzinska, Maria
    Chin, Richard F.
    Gil-Nagel, Antonio
    Gunning, Boudewijn
    Halford, Jonathan J.
    Mitchell, Wendy
    Scott Perry, Michael
    Thiele, Elizabeth A.
    Weinstock, Arie
    Dunayevich, Eduardo
    Checketts, Daniel
    Devinsky, Orrin
    EPILEPSIA, 2021, 62 (09) : 2228 - 2239
  • [30] Open-Label, Phase II Study to Assess the Efficacy and Safety of Canakinumab Treatment in Active Hyperimmunoglobulinemia D With Periodic Fever Syndrome
    Arostegui, Juan I.
    Anton, Jordi
    Calvo, Inmaculada
    Robles, Angel
    Iglesias, Estibaliz
    Lopez-Montesinos, Berta
    Banchereau, Romain
    Hong, Seunghee
    Joubert, Yolandi
    Junge, Guido
    Pascual, Virginia
    Yague, Jordi
    ARTHRITIS & RHEUMATOLOGY, 2017, 69 (08) : 1679 - 1688